QRXPHARMA LTD of NORTH SYDNEY NSW 2060, C3, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-30. The offering totals $12.4M, of which $12.4M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Peter W Campbell | Director | North Sydney, C3 |
| Peter W Farrell | Director | North Sydney, C3 |
| John W Holaday | Director | ROCKVILLE, MD |
| Gary W Pace | Director | San Diego, CA |
| Michael W Quinn | Director | North Sydney, C3 |
| Chris W Campbell | Executive Officer | North Sydney, C3 |
| John W Holaday | Executive Officer | ROCKVILLE, MD |
| Warren W Stern | Executive Officer | North Sydney, C3 |